Navigation Links
Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
Date:3/11/2011

need. For more information visit www.halozyme.com.

Safe Harbor StatementIn addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the timing and scope of our clinical trials as well as expected activities under our collaborative partnerships) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including regulatory approval requirements and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.Halozyme ContactRobert H. UhlSenior Director, Investor Relations(858) 704-8264ruhl@halozyme.comHalozyme Therapeutics, Inc.Condensed Consolidated Statements of OperationsThree Months EndedTwelve Months EndedDecember 31, December 31, 2010200920102009(unaudited)(unaudited)REVENUES:Product sales

$
200,078$
301,580$
895,518$
970,847Revenues under collaborative agreements

3,372,4466,142,31312,728,59712,700,458Total revenues

3,572,5246,443,89313,624,11513,671,305OPERATING EXPENSES:Cost of product sales

888,870159,952985,283311,891Research and development

15,933,02914,850,29451,773,50456,614,266Selling, general and administrative

4,634,3924,109,84515,122,96015,203,408Total operating ex
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
2. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
3. Halozyme Therapeutics Realigns Management
4. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
5. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
6. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
7. Halozyme Therapeutics Announces Public Offering of Common Stock
8. Halozyme Provides HYLENEX® Product Reintroduction Update
9. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
(Date:3/27/2015)... YORK , March 27, 2015  Delcath ... pharmaceutical and medical device company focused on oncology ... and metastatic liver cancers, announces the reporting of ... Company,s Melphalan Hydrochloride for Injection with the Delcath ... a poster presentation at the Society of Surgical ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
(Date:3/27/2015)... Ticket Down is a reputable source of authentic ... Nebraska on Friday, May 8th and Saturday, May 9th. ... added in Omaha as Garth has done in other markets ... World Tour is continuing its run throughout the United States ... Trisha Yearwood will bring their act to Omaha, NE at ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Endure ... Yoga for functional fitness athletes. This new program matches ... specific protocol for post-workout cool down. This program utilizes ... breath control and mental focus. , Karen Lefurgy, ... started practicing yoga long before I started Crossfit® training, ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global MEMS ... SM1120 MEMS based ultra-miniature pressure sensor designed especially for ... only 220um x 75um provides ample space for 1-French ... With industry leading in vivo drift performance of ... operating pressure range from 0 to 1,100 mmHg absolute. ...
(Date:3/27/2015)... March 27, 2015 Operatic contenders and ... greatness on April 17th. The universally acclaimed baritone Sherrill ... 9th annual Opera Idol at The Merion in Evanston. ... which has drawn aspiring opera singers from around the ... some of the finest young talent in the country,” ...
(Date:3/27/2015)... Dallas, Texas (PRWEB) March 27, 2015 ... Global Glutathione Industry is a professional and in-depth ... glutathione market with a focus on ... basic overview of the industry including definitions, classifications, ... analysis is provided for both the international and ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 3
... Cancer ... PETCO and Blue Buffalo are partnering to raise awareness and funds to fight this devastating disease. ... the Morris Animal Foundation to fund research and finding a cure. , ... Wilton, Conn., and San Diego (PRWEB) April 24, 2010 ...
... ... on hospitals caused by shorter working hours for junior doctors. , ... London (PRWeb UK) April 23, 2010 -- HCL ... part of HCL plc, said today that greater use of flexible and locum doctors ...
... 25th Anniversary EAU Congress ended in Barcelona on Tuesday ... interest and commitment shown by all participants, exhibitors and ... most memorable in the EAU,s congress history." ... due to the vulcanic eruption in Iceland which prevented ...
... and doctors have known for a long time that children ... considerably shorter than most other children. But pediatricians needing to ... set of growth charts based on data collected more than ... advances in the medical care of children with Down syndrome. ...
... ASHT to ... ... Society of Hand Therapists (ASHT) is hosting two meetings for the hand therapy community over ... , , ,ASHT will first hold its 33rd Annual Meeting on June 23. The meeting’s ...
... but opponents call decision a ,rubber stamp, , THURSDAY, ... year of study, a specially appointed panel at the ... guidelines for the treatment of Lyme disease are correct ... adopted in 2006, have long advocated for the short-term ...
Cached Medicine News:Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 2Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 3Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 4Health News:HCL Thames Medics says more locum doctors could help address European Working Time Directive shortage 2Health News:Memorable 25th Anniversary EAU Congress in Barcelona ends with awards 2Health News:Nutrition researchers to develop new growth charts for children with Down syndrome 2Health News:Two Hand Therapy Organizations Collaborate on Jam-Packed Educational Weekend 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 3Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 4
The microprocessor-controlled, Norm-O-Temp® total body hyperthermia water system provides effective heat therapy at less than half the cost of a hyper-hypothermia system....
The control unit manage patient temperatures during long complex surgical procedures to help achieve optimal clinical outcomes....
... T5002 has it's temperature set by ... by pressing a button. A green ... and a flashing amber LED indicates ... temperature. A red LED and an ...
The Cocoon Convective Warming Machine is lightweight, compact and easy to use....
Medicine Products: